Skip to main content
Search
Newsletters
Watchlist
Latest in
TSX Today:
ENB-T
+0.39%
HNU-T
+11.96%
MFC-T
+0.62%
TD-T
-0.18%
SU-T
+0.71%
BMO-T
-0.67%
IVN-T
+1.28%
Search stocks, ETFs and Commodities
Instrument Name
Xortx Therapeutics Inc
Instrument Symbol
(XRTX-Q)
Instrument Exchange
NASDAQ
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
After Hours
Change
After Hours
Last Update
After Hours
Price
Volume
Summary
Charts
Profile
Financials
Statistics
Dividends
Price History
Analyst Estimates
Insiders
Xortx Therapeutics Inc
3710 - 33RD STREET NW
ALBERTA A1 T2L 2M1 CAN
P:
403-607-2621
F:
403-260-3501
http://www.xortx.com
Sectors & Indices
Sector
Industry
Employees
SIC-2834 Pharmaceutical Preparations
Medical - Drugs
Profile
XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.
Key Executives
Name
Title
Allen Warren Davidoff
CEO/Director/President
Amar Keshri
CFO
Stephen Haworth
Chief Medical Officer
Stacy Evans
Other Executive Officer
More from The Globe
The close: Stocks higher as investors focus on Fed moves
Yesterday
The close: Major North American indexes rise as megacap tech stocks rally
April 26, 2024
Why this money manager is venturing back into emerging markets and adding more U.S. tech
April 26, 2024
How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy
April 25, 2024
Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders
April 25, 2024
The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market
April 25, 2024
Fiera Capital’s largest shareholder looks to sell stake in company
April 24, 2024